Furthermore, H19 is associated with key clinical factors such as tumor size, clinical stage, lymph node metastasis, distant metastasis, and overall survival (OS), with studies suggesting its potential as biomarker in the progression of tumors [45,67]. The gene discussed is H19; the disease is metastatic malignant neoplasm in the lymph nodes.